PE20200794A1 - Composicion para su uso en la prevencion y el tratamiento de patologias del aparato cardiovascular - Google Patents

Composicion para su uso en la prevencion y el tratamiento de patologias del aparato cardiovascular

Info

Publication number
PE20200794A1
PE20200794A1 PE2020000102A PE2020000102A PE20200794A1 PE 20200794 A1 PE20200794 A1 PE 20200794A1 PE 2020000102 A PE2020000102 A PE 2020000102A PE 2020000102 A PE2020000102 A PE 2020000102A PE 20200794 A1 PE20200794 A1 PE 20200794A1
Authority
PE
Peru
Prior art keywords
treatment
composition
pathologies
prevention
cardiovascular system
Prior art date
Application number
PE2020000102A
Other languages
English (en)
Spanish (es)
Inventor
Andrea Lacorte
Germano Tarantino
Elisa Brilli
Original Assignee
Pharmanutra S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmanutra S P A filed Critical Pharmanutra S P A
Publication of PE20200794A1 publication Critical patent/PE20200794A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/1592—Iron
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/161—Magnesium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/70—Vitamins
    • A23V2250/714—Vitamin K
    • A23V2250/7144—Vitamin K2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PE2020000102A 2017-07-26 2018-07-26 Composicion para su uso en la prevencion y el tratamiento de patologias del aparato cardiovascular PE20200794A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102017000085412A IT201700085412A1 (it) 2017-07-26 2017-07-26 Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
PCT/IB2018/055586 WO2019021232A1 (en) 2017-07-26 2018-07-26 Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus

Publications (1)

Publication Number Publication Date
PE20200794A1 true PE20200794A1 (es) 2020-08-10

Family

ID=60451085

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2020000102A PE20200794A1 (es) 2017-07-26 2018-07-26 Composicion para su uso en la prevencion y el tratamiento de patologias del aparato cardiovascular

Country Status (19)

Country Link
US (1) US20200206157A1 (https=)
EP (1) EP3657963A1 (https=)
JP (2) JP2020528888A (https=)
KR (1) KR20200032691A (https=)
CN (1) CN111031813A (https=)
BR (1) BR112020000902B1 (https=)
CA (1) CA3070659A1 (https=)
CL (1) CL2020000170A1 (https=)
CO (1) CO2020000526A2 (https=)
EA (1) EA202090069A1 (https=)
IL (1) IL272138B2 (https=)
IT (1) IT201700085412A1 (https=)
JO (1) JOP20200012A1 (https=)
MA (1) MA49794A (https=)
MX (1) MX2020000806A (https=)
PE (1) PE20200794A1 (https=)
PH (1) PH12020550031A1 (https=)
WO (1) WO2019021232A1 (https=)
ZA (1) ZA202000461B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
WO2019237054A1 (en) 2018-06-08 2019-12-12 Epizon Pharma, Inc. Methods and compositions for preventing or treating calciphylaxis
IL279245B2 (en) 2018-06-08 2024-03-01 Epizon Pharma Inc Compositions comprising menaquinone-7 (mk-7) and/or menquinol for prophylaxis of tissue calcification
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
IT201900007311A1 (it) 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
CN114748486A (zh) * 2022-03-25 2022-07-15 南京盛德生物科技研究院有限公司 一种含有维生素k2改善心血管钙化的药物组合物及其制备方法与应用
JP2025518284A (ja) 2022-05-31 2025-06-12 リージョン スイダンマーク 冠動脈石灰化（ｃａｃ）の治療に使用するためのビタミンｋ２

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3860849B2 (ja) * 1994-04-28 2006-12-20 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗動脈硬化治療剤
WO1996039053A2 (en) * 1995-06-06 1996-12-12 Campbell Soup Company Mineral supplements for dietetic food
US6361800B1 (en) * 2000-04-13 2002-03-26 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
GB0220182D0 (en) * 2002-08-30 2002-10-09 Cardiovascular Res Inst Maastr Organic compounds
WO2005044189A2 (en) * 2003-10-28 2005-05-19 Emory University Dialysates and methods and systems related thereto
US20050281888A1 (en) * 2004-06-16 2005-12-22 Chandra Ranjit K Nutritional supplement for infants
US20060134226A1 (en) * 2004-11-16 2006-06-22 Todd Leonard Compositions useful to treat ocular neovascular diseases and macular degeneration
MX2008008009A (es) * 2005-12-23 2008-09-12 Ajay Gupta Composicion de nutricion parenteral que contiene hierro.
JP2009525277A (ja) * 2006-01-30 2009-07-09 グロボアジア エルエルシー 軟組織石灰化の回復、予防、遅延または安定化方法
US20100021573A1 (en) * 2008-07-22 2010-01-28 Michael J Gonzalez Compositions and methods for the prevention of cardiovascular disease
EP2380578A4 (en) * 2008-12-25 2013-09-04 Ibe Co Ltd BIOACTIVE AGENT, PHARMACEUTICAL PRODUCT, COSMETIC PRODUCT, AGENT PRESERVING FRESHNESS AND AGENT PROMOTING PLANT AND ANIMAL GROWTH
PH12013502396A1 (en) * 2011-05-20 2019-07-17 Friesland Brands Bv Composition comprising vitamin k2
ITMI20121350A1 (it) * 2012-07-31 2014-02-01 Alesco Srl Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro.
EP2886129A1 (en) * 2013-12-20 2015-06-24 VitaK B.V. Prevention and counteraction of diet-induced thrombosis risk
WO2016131993A2 (en) * 2015-02-20 2016-08-25 Vitak B.V. Vitamin k and capillary function
US11344575B2 (en) * 2016-08-15 2022-05-31 Summit Innovation Labs, LLC Vascular calcification prevention and treatment

Also Published As

Publication number Publication date
BR112020000902B1 (pt) 2024-03-12
KR20200032691A (ko) 2020-03-26
ZA202000461B (en) 2021-03-31
IT201700085412A1 (it) 2019-01-26
IL272138A (en) 2020-03-31
IL272138B1 (en) 2023-05-01
CO2020000526A2 (es) 2020-02-18
IL272138B2 (en) 2023-09-01
US20200206157A1 (en) 2020-07-02
WO2019021232A1 (en) 2019-01-31
EP3657963A1 (en) 2020-06-03
MX2020000806A (es) 2020-08-17
JP2023090869A (ja) 2023-06-29
CA3070659A1 (en) 2019-01-31
CN111031813A (zh) 2020-04-17
EA202090069A1 (ru) 2020-04-10
PH12020550031A1 (en) 2021-02-08
JP2020528888A (ja) 2020-10-01
BR112020000902A2 (pt) 2020-07-21
CL2020000170A1 (es) 2020-10-30
JOP20200012A1 (ar) 2020-01-26
MA49794A (fr) 2020-06-03

Similar Documents

Publication Publication Date Title
PE20200794A1 (es) Composicion para su uso en la prevencion y el tratamiento de patologias del aparato cardiovascular
CL2021001292A1 (es) Terapia de combinación que incluye un inhibidor de krasg12c y uno o más agentes farmacéuticamente activos adicionales para el tratamiento de cánceres
CL2018003588A1 (es) Uso de inhibidores de miostatina y terapias de combinación.
CL2020000422A1 (es) Composiciones de glp-1 y sus usos.
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
MX2019003363A (es) Composiciones farmaceuticas para usarse en la terapia de la blefaritis.
MX2020011104A (es) Composiciones farmaceuticas de compuestos terapeuticamente activos y sus metodos de uso.
MX2016009625A (es) Proteinas quimericas tipo fosfatasa alcalina.
CL2017001335A1 (es) Cápsulas blandas de calcifediol.
ECSP19057403A (es) Usos terapéuticos de un polvo de insectos
CL2018003319A1 (es) Compuestos de mic-1 y usos de estos.
MX2018002546A (es) Composiciones que comprenden un compuesto de urolitina.
MX388286B (es) Formulaciones de oxitocina que contienen magnesio y metodos de uso.
MX2022014634A (es) Metodos para la administracion linfatica de agentes activos.
BR112017012406A2 (pt) formulação com relação fixa de insulina glargina/lixisenatida
CL2019001746A1 (es) Amidas aromáticas de ácido carboxílico
MX2020002585A (es) Inhibidor de hdac combinado con un modulador del punto de control inmunitario para la terapia contra el cancer.
CL2019003288A1 (es) Una combinación farmacéutica para el tratamiento de un cáncer.
ZA201906153B (en) Pharmaceutical compositions for combination therapy
CL2017000884A1 (es) Composición farmacéutica para usarse en el tratamiento o la prevención de deficiencias de vitaminas y minerales en pacientes que han sido sometidos a cirugía de derivación gástrica
MX374705B (es) Composiciones que comprenden anakinra.
CO2018004803A2 (es) Compuestos oxa-diazaspiro que tienen actividad contra el dolor
MX383214B (es) COMPOSICIONES Y MÉTODOS DE USO DE ß-HIDROXI-ß-METILBUTIRATO (HMB) PARA AUMENTAR LA RECUPERACIÓN DE TRAUMA DE TEJIDO BLANDO.
MX384394B (es) Compuesto para uso en la prevención y tratamiento de enfermedades neurodegenerativas.
MX380433B (es) Combinación de trazodona y gabapentina para el tratamiento de dolor.